Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

GN Store Nord A/S (GGNDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
35.00-0.90 (-2.51%)
At close: 09:30AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close35.90
Open35.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range35.00 - 35.00
52 Week Range31.27 - 88.55
Volume106
Avg. Volume167
Market Cap4.471B
Beta (5Y Monthly)0.76
PE Ratio (TTM)30.17
EPS (TTM)1.16
Earnings DateN/A
Forward Dividend & Yield0.23 (0.65%)
Ex-Dividend DateMar 10, 2022
1y Target Est575.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for GGNDF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • GN STORE NORD
    Analyst Report: ResMed Inc.ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
Advertisement
Advertisement